Doctors & patients are saying about 'A-Fib.com'...
"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."
Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN
"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."
Jill and Steve Douglas, East Troy, WI
“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP.
Faye Spencer, Boise, ID, April 2017
“I think your site has helped a lot of patients.”Dr. Hugh G. Calkins, MD Johns Hopkins,
Baltimore, MD
2026 AF Symposium: More Abstract Summaries Vol. 2—A Wealth of New Findings
If you read my report 2026 AF Symposium Abstracts—A Wealth of New Findings, you know I am excited about this year’s AF Symposium Abstracts, i.e., concise summaries of research, presented as “posters” and posted on panels. There were 103 abstracts with a wealth of the latest information.
In the past, the topics of some abstracts have become so timely and important that the authors were invited to expand their presentation and appear as speakers at the next year’s AF Symposium.
I’ve written 10 more summaries for you. Here’s a sample of what you’ll find in my new report.
Abstracts posters line the hallway (over 100).
Good News! You Can Stop Blood Thinners After A-Fib Ablation—No More Anticoagulation For Life!
This is the most important abstract for us patients! The ALONE-AF trial showed that, after a catheter ablation and without recurrent A-Fib, there were no significant differences between stopping or continuing to take oral anticoagulants (OAC). Researchers found, at 2 years, A-Fib patients who had an ablation had a lower risk of stroke, systemic embolism, and major bleeding compared with patients who continued to take anticoagulants.
In the ALONE-AF trial, patients were stratified into low and high-risk groups according to their CHA2DS2-VASc score, then assigned to discontinuation or continuation subgroups. No major bleeding events occurred in either discontinuation group while 5 major bleeding events, including 2 hemorrhagic strokes, occurred in the continuation groups.
Sansa – Sleep apnea diagnostic patch
You Don’t Need to Undergo a Sleep Apnea Study Anymore—a Patch Worn on the Chest Does the Same Thing
Patients with Atrial Fibrillation often have sleep apnea, as well, where breathing stops and starts repeatedly during sleep, causing low blood oxygen and fragmented sleep. Traditional home sleep testing require lab provided equipment (pick up and return) and an uncomfortable face mask.
The SANSA device (Huxley Medical) is an FDA-cleared diagnostic patch worn on the chest while sleeping. It is a single-point-of-skin-contact diagnostic device that does not require additional attachments, wires, belts or hoses. …click to continue reading my latest Abstract summaries, Volume 2—>
2026 AF Symposium Presentation ballroom with panel speakers
